Kanabo Group Plc (KNB.L)

17.60 -0.15 (-0.85%) At close: 4:35PM BST

Kanabo Group Plc

59-60 Russell Square
137-139 Brent Street
London WC1B 4HP
United Kingdom

http://www.kanabogroup.com

Sector(s): Healthcare
Industry: Pharmaceutical Retailers
Full-time employees: 3

Key executives

Name	Title	Pay	Exercised	Year born
Avihu Tamir	CEO & Director	N/A	N/A	N/A
Michelle Tamir	Marketing Mang.	N/A	N/A	N/A
Howard Rubenstein	Company Sec.	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Kanabo Group Plc focuses on the research and development, production, and sale of medical cannabis products to treat CNS disorders in Europe. The company intends to distribute cannabis-derived products for medical patients; and non-THC products for CBD consumers. It also provides VapePod, a medically certified delivery system for cannabis extracts. The company was incorporated in 2016 and is based in London, the United Kingdom.

Corporate governance

Kanabo Group Plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.